Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.

Ítems similars

• Human T-Lymphotropic Virus, Associated Myelopathy and Leukemia: A Review
  per: Auwal, I. Kabuga, et al.
  Publicat: (2018-12-01)
• Human T-cell lymphotropic virus type I and adult T-cell leukemia/lymphoma outside Japan and the Caribbean Basin.
  per: Levine, P. H., et al.
  Publicat: (1988)
• Parkinsonism in a Patient with Human T-lymphotropic Virus 1 Myelopathy
  per: Afzal, Hasnain, et al.
  Publicat: (2018)
• Retinal vasculitis in human T-lymphotropic virus type I associated myelopathy.
  per: Sasaki, K, et al.
  Publicat: (1989)
• The rationale for immunotherapy in respiratory allergies.
  per: Norman, P. S.
  Publicat: (1978)